Home
Sandu Pharmaceuticals Ltd 52 Week High

Sandu Pharmaceuticals Ltd
NSE: SANDUPHARMA
YEARHIGH
Key Highlights
- The 52 Week HIGH of Sandu Pharmaceuticals Ltd is ₹ 69.5 as of 02 Apr 25 .
Company Fundamentals for Sandu Pharmaceuticals Ltd
Market Price of Sandu Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
02 Apr 2025 | 50 |
01 Apr 2025 | 50 |
28 Mar 2025 | 48.99 |
27 Mar 2025 | 46.23 |
26 Mar 2025 | 49.19 |
25 Mar 2025 | 50.22 |
24 Mar 2025 | 51.8 |
21 Mar 2025 | 52.69 |
20 Mar 2025 | 51.47 |
19 Mar 2025 | 51.99 |
Asset Value vs Market Value of Sandu Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Historical Revenue of Sandu Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Sandu Pharmaceuticals Ltd
Historical Net Profit of Sandu Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Sandu Pharmaceuticals Ltd
Sandu Pharmaceuticals Ltd News Hub
Sandu Pharmaceuticals AGM scheduled
Sandu Pharmaceuticals announced that the 39th Annual General Meeting (AGM) of the company will be he
Read more
13 Aug 24
Board of Sandu Pharmaceuticals recommends final dividend
Sandu Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 12
Read more
13 Aug 24
Sandu Pharmaceuticals consolidated net profit rises 54.55% in the June 2024 quarter
Net profit of Sandu Pharmaceuticals rose 54.55% to Rs 0.17 crore in the quarter ended June 2024 as a
Read more
13 Aug 24
Sandu Pharmaceuticals schedules board meeting
Sandu Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 August 2024
Read more
06 Aug 24